000 02115 a2200589 4500
005 20250516102205.0
264 0 _c20130116
008 201301s 0 0 eng d
022 _a1872-6240
024 7 _a10.1016/j.brainres.2012.06.050
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKumar, Anil
245 0 0 _aNeuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
_h[electronic resource]
260 _bBrain research
_cAug 2012
300 _a13-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmphetamine
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aAtorvastatin
650 0 4 _aCorpus Striatum
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Interactions
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aGlutathione
_xmetabolism
650 0 4 _aHeptanoic Acids
_xtherapeutic use
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aMale
650 0 4 _aMalondialdehyde
_xmetabolism
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aNADH Dehydrogenase
_xmetabolism
650 0 4 _aNitrites
_xmetabolism
650 0 4 _aOxidopamine
_xtoxicity
650 0 4 _aParkinsonian Disorders
_xchemically induced
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSimvastatin
_xtherapeutic use
650 0 4 _aTetrazolium Salts
650 0 4 _aThiazoles
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aSharma, Neha
700 1 _aGupta, Amit
700 1 _aKalonia, Harikesh
700 1 _aMishra, Jitendriya
773 0 _tBrain research
_gvol. 1471
_gp. 13-22
856 4 0 _uhttps://doi.org/10.1016/j.brainres.2012.06.050
_zAvailable from publisher's website
999 _c21939850
_d21939850